This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The University of Texas System, Myriad Genetics, Inc., Other. Active years: 1991-2014.
Location History:
- Houston, TX (US) (1991)
- Bellaire, TX (US) (2001 - 2014)
Company Filing History:
4 out of 5,622 
1 out of 122 
3 out of 834,307 Years Active: 1991-2014
Title: The Innovative Contributions of Peter A Steck
Introduction
Peter A Steck is a notable inventor based in Houston, TX, who has made significant contributions to the field of cancer research. With a total of 7 patents, his work focuses on the identification and characterization of tumor suppressor genes, which play a crucial role in understanding and treating various cancers.
Latest Patents
One of Steck's latest patents is for a tumor suppressor designated TS10Q23.3. This specific region of chromosome 10 (10q23.3) has been implicated in a series of studies as containing a tumor suppressor gene involved in gliomas and other human cancers. Within this region, a gene was identified, and its corresponding coding region represents a novel 47 kD protein. A domain of this product matches the conserved catalytic domain of protein tyrosine phosphatases, suggesting a potential functional role in phosphorylation events. Sequence analyses revealed that several exons of the gene were deleted in tumor cell lines, leading to its classification as a tumor suppressor. Further analyses have shown the presence of mutations in this gene in both glioma and prostate carcinoma cells. Methods for diagnosing and treating cancers related to this tumor suppressor, designated as TS10q23.3, are also disclosed in his patent.
Career Highlights
Steck has worked with the University of Texas System, contributing to various research initiatives and projects. His work has been instrumental in advancing the understanding of cancer biology and the development of potential therapeutic strategies.
Collaborations
Some of his notable coworkers include Samar A Jasser and Mark A Pershouse, who have collaborated with him on various research projects.
Conclusion
Peter A Steck's innovative work in identifying tumor suppressor genes has made a significant impact on cancer research. His contributions continue to pave the way for advancements in cancer diagnosis and treatment.